Company profile: Leyden Labs
1.1 - Company Overview
Company description
- Provider of a mucosal immunity platform targeting commonalities of viral families to protect against known and future respiratory viruses, offering intranasal antibody sprays for immediate antiviral protection, including PanFlu nasal spray (CR9114 antibody) for broad influenza protection.
Products and services
- Mucosal Immunity Platform: Broad-spectrum system targeting viral family commonalities to harness mucosal immunity, protecting against known and future respiratory viruses
- Intranasal Antibody Sprays: Antibody-based sprays delivering antibodies directly to the nasal mucosa for immediate antiviral protection against respiratory viruses
- PanFlu™: A mucosal-administered nasal spray containing the CR9114 antibody, engineered for broad protection against influenza viruses via intranasal delivery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Leyden Labs
NanoView Biosciences
HQ: United States
Website
- Description: Provider of proprietary products supporting research, translation and delivery of precision medicine, built on a novel platform that uniquely identifies and characterizes exosomes. Offers high-throughput, cost-effective analysis, including Leprechaun for lentivirus and exosome biophysical characterization, contaminant detection, and concentration measurement using fluorescence and antibody-based methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoView Biosciences company profile →
Cytovale
HQ: United States
Website
- Description: Provider of early detection diagnostic technologies for immune-mediated diseases, including the IntelliSep Test for rapid sepsis identification with results in under 10 minutes to aid emergency department triage, powered by microfluidics, precision imaging, and machine learning to analyze complex biological data and perform detailed cellular analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytovale company profile →
TriPharm
HQ: United States
Website
- Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriPharm company profile →
Biocure Technology
HQ: Canada
Website
- Description: Provider of biosimilars and CAR-T cell pharmaceutical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocure Technology company profile →
GlycoVaxyn
HQ: Switzerland
Website
- Description: Provider of biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology, developing and manufacturing immunogenic glycoprotein conjugate vaccines for a range of bacterial diseases, including pneumococcal and nosocomial infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GlycoVaxyn company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Leyden Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Leyden Labs
2.2 - Growth funds investing in similar companies to Leyden Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Leyden Labs
4.2 - Public trading comparable groups for Leyden Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →